AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,774,131 | +15.7% | 252,553 | +6.8% | 0.00% | 0.0% |
Q2 2023 | $11,039,804 | +1446.9% | 236,449 | +1167.6% | 0.00% | – |
Q1 2023 | $713,664 | -93.6% | 18,653 | -90.8% | 0.00% | -100.0% |
Q4 2022 | $11,125,934 | +37.4% | 203,028 | -14.7% | 0.00% | 0.0% |
Q3 2022 | $8,100,000 | +5300.0% | 237,886 | +2147.4% | 0.00% | – |
Q1 2022 | $150,000 | -32.1% | 10,585 | +1.5% | 0.00% | – |
Q4 2021 | $221,000 | -15.0% | 10,429 | -10.5% | 0.00% | – |
Q3 2021 | $260,000 | +4.4% | 11,656 | +16.2% | 0.00% | – |
Q2 2021 | $249,000 | – | 10,029 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |